We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 1.75879396985 | 3.98 | 4.19 | 3.95 | 3715 | 4.08956819 | DE |
4 | -0.22 | -5.15222482436 | 4.27 | 4.33 | 3.88 | 4796 | 4.07300783 | DE |
12 | -0.45 | -10 | 4.5 | 4.6 | 3.75 | 7284 | 4.22821271 | DE |
26 | 0.26 | 6.86015831135 | 3.79 | 4.6 | 3.61 | 7334 | 4.09654777 | DE |
52 | 1.02 | 33.6633663366 | 3.03 | 4.6 | 2.85 | 11863 | 3.63988698 | DE |
156 | 0.36 | 9.75609756098 | 3.69 | 4.6 | 2.15 | 10670 | 3.26221472 | DE |
260 | 0.35 | 9.45945945946 | 3.7 | 4.6 | 2.15 | 15050 | 3.50416172 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions